Bookmark and Share

Last Minute: "Nicola Sturgeon blasts 'vicious' Tory civil war after confidence vote called - Daily Mail" Wed, 12 Dec 2018 10:46:00 GMT    "'Raging' Santa angers parents with beard-ripping tantrum - The Guardian" Wed, 12 Dec 2018 19:32:00 GMT    "Michael Cohen blames Trump's 'dirty deeds' as he is jailed - BBC News" Thu, 13 Dec 2018 00:12:49 GMT    "'Very vulnerable' British man, 23, missing in Madrid is found dead - Daily Mail" Wed, 12 Dec 2018 20:40:00 GMT    "Ireland's economy 'threatened by Tory fundamentalists' - The Guardian" Wed, 12 Dec 2018 17:09:00 GMT    "Jacob Rees-Mogg says Theresa May should 'meet the Queen and resign' despite winning confidence vote - Evening Standard" Wed, 12 Dec 2018 22:29:00 GMT    "Canada Goose shares slide amid Beijing-Ottawa row over Huawei CFO arrest - The Guardian" Wed, 12 Dec 2018 19:09:00 GMT    "Catholic Church's third most senior cleric is removed from Pope's inner circle over sex abuse claims - Daily Mail" Thu, 13 Dec 2018 00:19:00 GMT   "Thursday's national newspaper front pages - Sky News" Wed, 12 Dec 2018 22:40:37 GMT    "Theresa May faces Tory leadership battle in run-up to Christmas as Tories hand in 48 letters needed to - The Sun" Wed, 12 Dec 2018 00:34:00 GMT      For more news, click here.

Remember me? 

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Pfizer -  [Ticker: PFE] chart
Change to Pfizer Interactive Technical Analysis Chart

Last 10 Forum Topics about Pfizer:
No topics about Pfizer [PFE] have been found, but a search on the Forum for more topics related to Pfizer is advised.

 News about Pfizer [PFE]:   (ordered by relevance)
Senator to Pfizer CEO: Stop playing 'political games' with drug prices  FiercePharma

Once again, Pfizer is in hot water with a politician for raising prices. This time, it's Sen. Tammy Baldwin, D-Wis., who's accusing the drugmaker of playing ...

Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan

JP Morgan downgrades Pfizer (PFE) on assumptions that the market has discounted all growth factors for Pfizer.

Pfizer UK names new managing director  PharmaTimes

Pfizer has announced the appointment of Ben Osborn as managing director in the UK, taking over from Erik Nordkamp, who will now become general manager ...

Pfizer still unable to get on top of problems at Hospira injectables plant  FiercePharma

Since Pfizer's Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the ...

JP Morgan downgrades Pfizer, saying stock has moved too far, too fast: 'Moving to the sidelines'  CNBC

J.P. Morgan downgraded Pfizer shares to neutral from overweight on Tuesday, warning clients that the stock's rally will likely slow after climbing more than 22 ...

Report: Developing Opportunities within Pfizer, Bed Bath & Beyond, Vishay Intertechnology, Cloudera, Markel, and QTS Realty Trust ? Future Expectations, Projections Moving into 2018  Nasdaq

NEW YORK, Dec. 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for.

Pfizer Slips Lower After JPMorgan Downgrade on Patent Cycle Concerns

Pfizer shares slipped lower in pre-market trading Tuesday after analysts at JPMorgan lowered their rating for the drugmaker amid concerns of the loss of ...

Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $44.40, marking a +1.09% move from the previous day.

Trendy Stock Active Limelight ? Pfizer Inc. (PFE)  Stock News Stop

Pfizer Inc. (PFE) plunged -0.88% with the finishing price of $44.01 in Tuesday Trading Session. The stock price showed -5.29% lower in value from one year ...

Pfizer Price Increases Underscore Rebate Problem, HHS' Hargan Says  Scrip

The Trump Administration remains convinced that rebates lead to high list prices and that reform of the system is needed, US HHS Deputy Secretary Eric Hargan ...

Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more  CNBC

Check out the companies making headlines before the bell: DSW ? The shoe retailer reported adjusted quarterly profit of 70 cents per share, above the ...

Genentech and Pfizer Reach Settlement Over Biosimilar Trastuzumab  The Center for Biosimilars

Recently, plaintiff Genentech and defendant Pfizer filed a collective stipulation and proposed order of dismissal of a patent infringement lawsuit over ...

Pfizer to raise drug prices despite Trump complaints  CNN

New York (CNN Business) Pfizer is planning to raise prices on 41 drugs in January, a few months after the company agreed to defer hikes under heavy pressure ...

AbbVie, Pfizer reach licencing agreement for biosimilar Humira  pharmaphorum

AbbVie has granted a patent license allowing Pfizer to sell its Humira (adalimumab) biosimilar in many countries around the world.

Pfizer to hike prices of 41 drugs despite Trump criticism  pharmaphorum

Pfizer plans to raise the prices of 41 prescription drugs in January, despite falling foul of President Trump, who criticised the company's stance on costs earlier ...

Pfizer strikes deal with Chinese online pharmacy Jianke  pharmaphorum

Pfizer is to launch a new retail, hospital and internet healthcare strategy in China as part of a deal with local online pharmacy Jianke.

Pfizer could owe NHS £500m for extending pregabalin patent for pain  The BMJ

BMJ 2018; 363 doi: (Published 15 November 2018) Cite this as: BMJ 2018;363:k4856. Article; Related *content*; Metrics ...

Get Back into Growth Stocks Like Pfizer Inc. (PFE), Exxon Mobil Corporation (XOM)  Financial Mercury

Looking at top Wall Street opinions, Pfizer Inc. (NYSE: PFE) has recently made its way into the research list of JP Morgan ? signaling that their analyst's rating ...

Pfizer McPherson site hit with US FDA repeat observations

Pfizer's sterile drug manufacturing site in Kansas received eight observations during an FDA inspection. Following its acquisition of Hospira in 2015, Pfizer has ...

Pfizer Inc (PFE) Rising Higher 0.36% Over the Past Four Weeks  Martin Business Telegraph

Pfizer Inc (PFE) shares are currently showing up on the list of gainers over the past month. During that time period, shares have seen a rise of 0.36%. Heading.

Pfizer Is in Breakout-Mode This Fall: Chart  TheStreet

A classic technical breakout in shares of Pfizer points to more upside ahead in this healthcare giant....PFE.

Little Or No Wiggle Room For Pfizer Inc. (PFE), DowDuPont Inc. (DWDP)?  GV Times

8 analysts out of 18 Wall Street brokerage firms rate Pfizer Inc. (NYSE:PFE) as a Buy, while 2 see it as a Sell. The rest 8 describe it as a Hold. PFE stock traded ...

Pfizer's failed pregabalin patent appeal means NHS could reclaim £502m  Pulse

The NHS could claim back over half a billion pounds from Pfizer - following a long-running controversy that saw GPs having to switch patients between branded ...

Pfizer (PFE) Stock Moves -1.78%: What You Should Know

Pfizer (PFE) closed the most recent trading day at $45.17, moving -1.78% from the previous trading session.

An FDA inspection report shows just how troubled a Pfizer plant really is  STAT

Yet another inspection by the Food and Drug Administration underscores the difficulties that Pfizer (PFE) is having with a key plant that has been responsible for ...

Pfizer Receives FDA Approval For AML Drug  Seeking Alpha

Pfizer announced that it had received FDA approval for DAURISMO to treat newly diagnosed elderly patients with acute myeloid leukemia. The FDA approved ...

Pfizer Inc. (NYSE:PFE)'s Suggested Target Weight Stands at 4.440% For Portfolios  Martin Business Telegraph

A recent look at ownership and volatility brings us to a 4.440% target portfolio weight (as a decimal) for Pfizer Inc. (NYSE:PFE) Target weight is the.

Pfizer Gets Global Patent License for AbbVie's Humira  Pharmaceutical Technology Magazine

AbbVie will grant Pfizer license to launch a biosimilar to AbbVie's Humira worldwide.

Pfizer wins blockbuster Lyrica patent extension to safeguard sales till June  FiercePharma

Pfizer, looking to protect billions in Lyrica sales, has been gunning for a 6-month pediatric exclusivity extension for its top drug. And on Tuesday, the FDA came ...

FDA approves new blood cancer treatment from Pfizer  Reuters

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a ...

Merck and Pfizer chalk up another fail for Bavencio  pharmaphorum

Merck KGaA and Pfizer's late entrant to the checkpoint inhibitor category has failed a phase III trial in ovarian cancer.

unusual options activity bullish buying tjx companies pfizer  CNBC

"Halftime Report" trader Jon Najarian spots bullish option buying in TJX Companies and Pfizer.

Stock Rating Update on the Shares of Pfizer Inc (PFE) and Borgwarner Inc (BWA)  Post Registrar

Pfizer Inc (NYSE:PFE)'s share price plunged -0.88% or -0.39 to reach at $44.01 during previous trading session. A total of 22.68 Million shares exchanged ...

Where Will Pfizer Inc. Be in 5 Years?  The Motley Fool

With a little momentum at the end of 2018, Pfizer Inc. (NYSE:PFE) could be headed for its best year yet in the 21st century. The big pharma stock is absolutely ...

On a roll with FDA approvals, Pfizer doubles down in AML with Daurismo nod  FiercePharma

Make that four drug approvals for Pfizer's oncology unit in less than two months. In a welcome streak for the pharma giant?what with Lyrica generics ...

Approaching At A Risky Level: Pfizer Inc., (NYSE: PFE), OncoSec Medical Incorporated, (NASDAQ: ONCS)  Nyse Trading News

Intraday Trading of Pfizer Inc.: The Healthcare stock finished its last trading at $44.01 while performed a change of -0.88% (Loss, ?) on 11-12-2018 (Tuesday).

Pfizer, AbbVie settle Humira biosimilar dispute  Crain's Chicago Business

Another Humira biosimilar is primed to enter the U.S. market in 2023.

Pfizer and Merck are raising drug prices again, showing that their price cuts were just a sham to mollify Trum  Los Angeles Times

It's hard to believe that anyone was taken in this summer when a handful of drug companies announced rollbacks of price increases or price freezes on some of ...

Pfizer gets first FDA nod for hedgehog inhibitor in AML  PMLiVE

Pfizer has added to a run of new product approvals for acute myeloid leukaemia (AML) with an FDA nod for Daurismo, the first smoothened (SMO) receptor ...

Pfizer Kansas plant hit by FDA 483 with 8 repeat observations  BioProcess Insider

The US FDA observed potentialmold contamination and deficient aseptic processes during an inspection at Pfizer's fill/finish facility in McPherson, Kansas.

Pfizer Inc. (PFE) is generating Dividend Yield of 3.09%  Stocks Gallery

Shares of Pfizer Inc. (PFE) moved -0.88% in the recent trading day. Last trading transaction put the stock price at $44.01. After going under observation of traders ...

China's online healthcare platform enters into strategic collaboration with Pfizer  MobiHealthNews, China's online healthcare platform, yesterday announced during the Jianke Doctor Rebrand & 2018 Jianke Partners' Conference in Shanghai that ...

Pfizer reports positive 26-week results from REFLECTIONS B328-06 study  Drug Development Technology

Pfizer has reported positive 26-week data from the ongoing REFLECTIONS B328-06 study, a Phase lll trial of PF-05280586 for CD20-positive lymphoma.

Better Buy: Pfizer vs. Bristol-Myers Squibb  The Motley Fool

Two big pharma stocks. Two potential winners. But which is the better pick for long-term investors?

Pfizer Inc. (PFE) Management Presents on Evercore ISI HealthCONx Conference Call Transcript  Seeking Alpha

Call Start: 08:45 Call End: 09:28 Pfizer Inc. (NYSE:PFE) Evercore ISI HealthCONx Conference Call November 29, 2018 08:45 ET Executives Chuck Triano - SVP ...

AstraZeneca and Pfizer drugs reimbursed in Australia  The Pharma Letter

The Australian government will list new medicines for severe asthma and growth hormone deficiency on its Pharmaceutical Benefits Scheme (PBS).

Pfizer and AT&T among companies distancing themselves from Hyde-Smith  Daily Mail

Drug companies and tech firms are among those withdrawing support from Republican Cindy Hyde-Smith in the final hours of her Senate runoff as her 'public ...

Pfizer Inc. (PFE)- Stocks Raising Investors Eye Brows  NASDAQ Times

Pfizer Inc. (NYSE:PFE) traded under umbrella of Healthcare sector, shares knocked down -0.88% to trade at $44.01 in the last beat. By excluding these ...

Pfizer Inc. (PFE) returned 0.36% higher over current month  Stock Market Floor

Pfizer Inc. (PFE)'s last traded at $44.01 and with moved of -0.88% on 11-Dec-18 compared to daily average volume of 23.04 million shares. When we divide the ...

Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, ex-Facebook President Sean Parker condemns hanging comment, does not request money back  CNBC

Pfizer joins Walmart, AT&T, Boston Scientific, Union Pacific, and Leidos in asking for campaign contributions to be returned.

Lawmaker chastises Pfizer for reverting to price hikes next month  STAT

Sen. Tammy Baldwin chastised Pfizer for ?playing political games? with price hikes and failing to answers questions about freezes made in July.

Why Pfizer Is Up 19% in 2018 So Far  Motley Fool

Here's what has investors revved up about the big pharma stock.

Pfizer publicly announces recall of muscle and menstrual pain wraps it yanked Oct. 2  The State

Pfizer publicly announced Monday a recall of ThermaCare HeatWrap products for muscle pain or menstrual pain that can leak and cause burns or blisters.

Stocks to watch: WPP, 888, Pfizer, Aviva, Standard Life, BASF, Total  Financial Times

Superdry's turnround may require another year of clearance sales, says Berenberg.

Monday?s Vital Data: Pfizer, Goldman Sachs and Caterpillar

Options trading was buzzing in Pfizer, Goldman Sachs and Caterpillar on Friday. Here are the metrics that matter moving forward.

For sober investments this stock should be considered:: Pfizer Inc., (NYSE: PFE), Liberty Global plc, (NASDAQ: LBTYK)  Global Export Lines

Earnings for each Share (EPS) are the part of a company's profit allocated to respectively outstanding share of common stock. EPS serves as a pointer to a ...

Pharma giant Pfizer to raise some drug prices  Medical Xpress

Pfizer said Friday it would raise US prices on 41 drugs in January, reversing a price freeze implemented over the summer in the face of criticism by President ...

Strategic Global Advisors Increased Its Pfizer (PFE) Position; Ws Management Lllp Lifted By $11.49 Million Its Mosaic Co New (MOS) Stake  The FinExaminer

Strategic Global Advisors Llc increased Pfizer Inc (PFE) stake by 9.4% reported in 2018Q3 SEC filing. Strategic Global Advisors Llc acquired 8628 shares as Ws ...

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference  Business Wire

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Chris Boshoff, senior vice president and head, Immuno.

Trust Co Of Vermont Trimmed Pfizer (PFE) Holding by $325,952 as Valuation Rose; Jacobs Asset Management Lifted Its Ameris Bancorp (ABCB) Stake by $5.20 Million  The FinExaminer

Trust Co Of Vermont decreased its stake in Pfizer Inc (PFE) by 2.62% based on its latest 2018Q3 regulatory filing with the SEC. Trust Co Of Vermont sold 7408 ...

Brainstorm Health: HIV Prevention Pill, Pfizer Price Hikes, Chickenpox Outbreak  Fortune

Greetings, readers! On Tuesday, the U.S. Preventive Services Task Force (USPSTF), the government body tasked with, well, recommending preventive health ...

Pfizer loses Lyrica patent fight - Latest Pharmacy News | Business | Magazine  Pharmacy Business

Pfizer lost the final round in a lengthy patent battle after the Supreme Court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the ...

Pfizer (PFE) Position Has Boosted by Jnba Financial Advisors; Ppl (PPL) Shareholder Mycio Wealth Partners Upped Its Position by $404,144 as Shares Rose  The FinExaminer

Jnba Financial Advisors increased its stake in Pfizer Inc. (PFE) by 1222.08% based on its latest 2018Q3 regulatory filing with the SEC. Jnba Financial Advisors ...

Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer  GlobeNewswire

Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019. CALGARY, Alberta, Nov.

Why Pfizer Amyloidosis Drug Tafamidis Could Lead These 2 Biotech Stocks Rival Treatments  Investor's Business Daily

Pfizer amyloidosis drug Tafamidis will get most of the market for the rare disease, with Alnylam and Ionis fighting for the rest, an analyst said.

Pfizer (PFE) Holder American Investment Services Trimmed Its Holding; Guidewire Software (GWRE) Holder Cabot Wealth Management Boosted Its Stake by $1.93 Million as Stock Price Declined  The FinExaminer

American Investment Services Inc decreased its stake in Pfizer Inc (PFE) by 15.55% based on its latest 2018Q3 regulatory filing with the SEC. American Cabot ...

Supreme Court dismisses Pfizer's bid for patent protection of pregabalin  The Pharmaceutical Journal

The Supreme Court has dismissed a bid by drug company Pfizer to strengthen the patent protection of pregabalin (Lyrica).

Pfizer Inc. issues voluntary nationwide recall of Thermacare Heatwraps  Wink News

Pfizer Inc. has issued a voluntarily recall on six lots of Thermacare heatwraps. Pfizer says the wraps can leak and could cause skin injuries to users. The use of a ...

Pfizer (PFE) Gains As Market Dips: What You Should Know

Pfizer (PFE) closed the most recent trading day at $44.20, moving +1.57% from the previous trading session.

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial  MarketWatch

Merck KGaA MKKGY, +0.59% and Pfizer Inc. PFE, +1.09% said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a ...

Pfizer to raise drug prices despite complaints by President Trump  FOX 31 Denver

Pfizer is planning to raise prices on 41 drugs in January, a few months after the company agreed to defer hikes under heavy pressure from President Donald ...

Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting  Global Banking And Finance Review

Pfizer Inc. (NYSE:PFE) announced today at the American Society of Hematology Annual Meeting that the REFLECTIONS B328-06 study, a comparative safety ...

Health Care Sector Update for 12/12/2018: SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN  Nasdaq

Top Health Care Stocks: JNJ: +0.66% PFE: +0.59% ABT: Flat MRK: Flat AMGN: +1.15% Health care stocks were flat to higher pre-bell Wednesday. Stocks.

Pfizer Q2 net profit falls 14% to Rs 95.8 crore  Economic Times

New Delhi, Nov 14 () Drug firm Pfizer Wednesday reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September 2018.

FDA Approves New Cancer Drugs from Pfizer and Loxo Oncology  Pharmaceutical Technology Magazine

The agency has approved two new chemical entities, Daurismo (glasdegib) from Pfizer, and Vitrakvi (larotrectinib) from Loxo Oncology, for treating cancers.

Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin)  Global Banking And Finance Review

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for LYRICA. This grant extends t.

Enzyme Replacement Therapy Market 2018-2023 By Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences  Journal of Industry

Global Enzyme Replacement Therapy Market Report 2018-2023, describes an in-depth evaluation and professional study on the present and future state of the ...

Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs

FDA grants approval to Pfizer's (PFE) new cancer drug and label expansion of AbbVie/Roche's Venclexta. CHMP gives nod to several drugs.

Why Pfizer Inc. (NYSE:PFE) Has Continued to Shine  FDA Headlines

Nov 21, 2018 | Business. Why Pfizer Inc. (NYSE:PFE) Has Continued to Shine. Pfizer Inc. (NYSE:PFE) shares have been sharp outperformers relative to both the ...

Allergan says tossing Pfizer lawsuit could endanger potential opioid accord  Reuters

Allergan PLC says the chances of reaching a global settlement in the federal opioid litigation could be jeopardized if a judge dismisses a lawsuit seeking to force ...

Health Care Sector Update for 12/12/2018: XBIT, SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN  Nasdaq

Top Health Care Stocks:JNJ: +1.04%PFE: +1.43%ABT: +2.41%MRK: +1.78%AMGN: +1.10%Most health care stocks were climbing this afternoon, including a ...

Stock Rating Update on the Shares of Pfizer Inc (PFE) and Mylan Nv Ord Shs (MYL)  Post Registrar

Pfizer Inc (NYSE:PFE)'s share price soared 1.09% or 0.48 to reach at $44.4 during previous trading session. A total of 24.85 Million shares exchanged hands, ...

Pfizer launches biosimilar version of Amgen's Epogen  BioPharma Dive

Pfizer on Wednesday announced the U.S. launch of its third biosimilar product, creating a new market threat to Amgen's Epogen and Johnson & Johnson's ...

UK Supreme Court rules against Pfizer in landmark second medical use patent case  Zenopa

The Supreme Court has now agreed that patent claims relevant to the neuropathic pain indications are invalid.

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More  24/7 Wall St.

Stocks managed to recover handily from Monday's losses and the futures were indicated to open higher by over 1% for the Dow Jones industrials, S&P 500 and ...

Carlos Ghosn, Apple, US-China Trade, Bitcoin and Pfizer - 5 Things You Must Know

Reports suggest Renault CEO Carlos Ghosn faces arrest in Japan after Nissan said he had misused company funds and will be ousted as chairman; Apple is ...

Pfizer Unveils New Double-Sided EpiPen For Lovers  The Onion

NEW YORK?Marketing the emergency auto-injector as the perfect product for romantic evenings when you and a partner go into anaphylactic shock ...

Aileron, Pfizer form clinical trial collaboration for ALRN-6924, palbociclib  Drug Development Technology

Aileron Therapeutics has entered a clinical trial collaboration with Pfizer to evaluate the combination of ALRN-6924 and palbociclib in MDM2-amplified cancers.

Code recreates Pfizer's 1956 effort to procedurally generate drug names  Boing Boing

Procedural generation isn't just for video game landscapes and galaxies. The technique for creating vast amounts of realistic but uncannily superficial *content* ...

Aileron Enters Clinical Trial Collaboration with Pfizer to Evaluate ALRN-6924 in Combination with IBRANCE® (palbociclib) in MDM2-Amplified Cancers  GlobeNewswire

WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, ...

Stocks To Watch Today: Oracle Corporation (ORCL) And Pfizer Inc. (PFE) On The Marquee  GV Times

The price of Oracle Corporation (NYSE:ORCL) went down by -$2.07 now trading at $46.68. Their shares witnessed a 9.65% increase from the 52-week low price ...

Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study  GlobeNewswire

Press Release. 16 November 2018. Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel ...

ERS kicks off Pfizer teardown | Local News  Plattsburgh Press Republican

ROUSES POINT ? Demolition of the Pfizer buildings has already begun here, and redevelopment plans are in the works, the facility's new owner says.

Wall Street Consensus Target Update for Pfizer Inc. (NYSE:PFE)  Martin Business Telegraph

Investors are constantly trying to gain any little advantage when studying potential stocks to add to the portfolio. Keeping close tabs on Wall Street analyst.

are spangling Stocks Caesars Entertainment Corporation (NASDAQ:CZR), Pfizer Inc. (NYSE:PFE), Acorda Therapeutics, Inc. (NASDAQ:ACOR)  Market Breaking Point

On Tuesday, Caesars Entertainment Corporation (NASDAQ:CZR) reached at $7.17 price level during last trade its distance from 20 days simple moving average ...

Pfizer Stock Has Multiple Positive Catalysts

Pfizer stock could be boosted by the company's rising investments and strong pipeline. PFE stock would be attractive on a major drop.

Global Pediatric Nutrition Market 2019- Pfizer, Kraft Heinz, Danone  Journal of Industry

Global Pediatric Nutrition Market Research Report primarily introduces market demands and the current position of the Pediatric Nutrition industry. It uncovers ...

Pfizer Inc. (NYSE:PFE):- 0.90 Beta Check and Performance Review  Martin Business Telegraph

Examining shares of Pfizer Inc. (NYSE:PFE), we can see that the stock has a current beta of 0.90. Checking in on current price action, company shares had.

5 Pharma Stocks That Could Cure Ailing Portfolios in 2019

These pharma stocks offer low multiples and growth catalysts that could offer relief to investors in the coming year.

?Global Oncology Biosimilars Market 2018 ? Celltrion Inc., Pfizer Inc., Biocon, BIOCAD, Apotex Inc., Dr. Reddy's, Sandoz International GmbH ? Industry Research Now  Industry Research Now

The Global Oncology Biosimilars Market provides an in-depth look and share detailed information about the key factors influencing the growth of the market ...

For more news about Pfizer click here:
Pfizer News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2018 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources